Severity
Moderate
FDA Drug recall · Reported November 25, 2020
GMP Deviations
Milbar Laboratories, Inc. recalled DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic C… - a moderate-severity action.
DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic C… was recalled by Milbar Laboratories, Inc. in November 25, 2020. Reason: GMP Deviations. Check the official notice for the remedy. Verify recall #D-0095-2021 with the FDA Drug before acting.
The recall
Milbar Laboratories, Inc. issued this moderate-severity FDA Drug recall-GMP Deviations.
Sourced from official FDA Drug enforcement records. Verify recall #D-0095-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0095-2021) was formally reported on November 25, 2020, with the manufacturer initiating the action on October 9, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. Milbar Laboratories, Inc. is listed as the recalling firm, operating out of East Haven, CT. Federal records list the affected scope as 927 tubes.
The documented reason for this recall is: GMP Deviations Distribution data in the federal record shows the product reached: Product was distributed throughout the United States, including Puerto Rico and internationally.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 1,360 cosmetics & personal care recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
927 tubes
Related Recalls
6
3 from same agency
DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA
GMP Deviations
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0095-2021 |
| Date reported | November 25, 2020 |
| Date initiated | October 9, 2020 |
| Recalling firm | Milbar Laboratories, Inc. |
| Firm location | East Haven, CT |
| Affected scope | 927 tubes |
| Distribution | Product was distributed throughout the United States, including Puerto Rico and internationally. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-06-04
PS Seasoning & Spices, Inc. · 2026-05-27
Fontana Flavors, Inc · 2026-05-27
Wisconsin Pharmacal Company · 2026-05-27
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-04-22
Compare this recall with Tiny Land Children's Play Tents Recalled Due to Risk of Inj… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported November 25, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.